Literature DB >> 9704644

Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation.

G Schett1, G Steiner, J S Smolen.   

Abstract

OBJECTIVE: To elucidate the nature of the antigen reactive with the "lupus erythematosus (LE) cell factor," the autoantibody involved in the LE cell phenomenon.
METHODS: Serum samples from systemic lupus erythematosus (SLE) patients who were positive for the LE cell phenomenon (LEc+) and SLE patients who were negative for the LE cell phenomenon (LEc-) were used to characterize the nuclear antigen bound by the LE cell factor, by immunoblotting and immunoprecipitation techniques.
RESULTS: All LEc+ sera, but none of the LEc- sera, uniformly reacted with a double band of MW approximately 30 kd in nuclear extracts. Depletion of nuclear protein extracts of antigens bound by pooled LEc- serum allowed precipitation of a low molecular weight protein by pooled LEc+ serum. This protein was able to block LE cell formation by LEc+ serum. Based on its reactivity with antihistone antibody and an electrophoretic mobility identical with that of precipitated and purified histone H1, this protein was identified as histone H1. Moreover, all LEc+ sera, but none of the LEc- sera, reacted with purified histone H1 by immunoblotting, whereas other histones were reactive with both types of sera. In addition, purified histone H1, but none of the other histones, strongly inhibited the induction of LE cells by LEc+ serum.
CONCLUSION: Histone H1 represents the major antigenic component recognized by the LE cell factor. Thus, the LE cell phenomenon appears to be due primarily to anti-histone H1 reactivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704644     DOI: 10.1002/1529-0131(199808)41:8<1446::AID-ART15>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

Review 1.  Towards a pro-resolving concept in systemic lupus erythematosus.

Authors:  Sebastian Boeltz; Melanie Hagen; Jasmin Knopf; Aparna Mahajan; Maximilian Schick; Yi Zhao; Cornelia Erfurt-Berge; Jürgen Rech; Luis E Muñoz; Martin Herrmann
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

2.  Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.

Authors:  E Touloupi; J G Routsias; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.

Authors:  Michele Compagno; Birgitta Gullstrand; Søren Jacobsen; Gro Ø Eilertsen; Jan Åke Nilsson; Christian Lood; Andreas Jönsen; Lennart Truedsson; Gunnar Sturfelt; Anders A Bengtsson
Journal:  Arthritis Res Ther       Date:  2016-02-10       Impact factor: 5.156

4.  Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus.

Authors:  Elinor A Chapman; Max Lyon; Deborah Simpson; David Mason; Robert J Beynon; Robert J Moots; Helen L Wright
Journal:  Front Immunol       Date:  2019-03-11       Impact factor: 7.561

Review 5.  Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.

Authors:  Michele Fresneda Alarcon; Zoe McLaren; Helen Louise Wright
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 8.786

6.  Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus.

Authors:  Mona H C Biermann; Sebastian Boeltz; Elmar Pieterse; Jasmin Knopf; Jürgen Rech; Rostyslav Bilyy; Johan van der Vlag; Angela Tincani; Jörg H W Distler; Gerhard Krönke; Georg Andreas Schett; Martin Herrmann; Luis E Muñoz
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.